Trials / Unknown
UnknownNCT01687374
Parathyroid Hormone for the Treatment of Humerus Fractures
Phase IV Study of the Effect of Parathyroid Hormone on Fractures of the Humerus
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Hvidovre University Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Hypothesis: The investigators want to study whether parathyroid hormone improves healing of humerus after a fracture. The investigators will assess healing of the humerus with Constant score.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 1-84 parathyroid hormone | 100 micrograms of 1-84 parathyroid hormone daily for 8 weeks, subcutaneous injection. |
| DRUG | Placebo | Saline injection daily for 8 weeks. |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2012-12-01
- Completion
- 2013-12-01
- First posted
- 2012-09-18
- Last updated
- 2012-09-18
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01687374. Inclusion in this directory is not an endorsement.